$CPSS
Consumer Portfolio Services Inc Stock $cpss

$cpss Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000168316822005436 Filed on August 08, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$90.31M	$82.02M	$71.97M
YoY Change	31.71%	22.84%	6.62%
Cost Of Revenue	$23.48M	$18.77M	$16.40M
YoY Change	28.08%	-1.1%	-21.53%
Gross Profit	$58.64M	$58.55M	$55.57M
YoY Change	16.74%	22.51%	19.24%
Gross Profit Margin	64.93%	71.38%	77.21%
Selling, General & Admin	$15.37M	$14.12M	$37.62M
YoY Change	-51.77%	17.34%	11.3%
% of Gross Profit	26.21%	24.11%	67.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$406.0K	$385.0K	$417.0K
YoY Change	-0.73%	-7.67%	4.25%
% of Gross Profit	0.69%	0.66%	0.75%
Operating Expenses	$55.96M	$47.80M	$28.64M
YoY Change	82.38%	-9.63%	-16.51%
Operating Profit	$2.678M	$10.75M	$26.93M
YoY Change	-86.3%	-310.52%	118.93%
Interest Expense	$23.48M	$18.77M	$2.400M
YoY Change		-1.1%	-154.55%
% of Operating Profit	876.89%	174.7%	8.91%
Other Income/Expense, Net
YoY Change
Pretax Income	$34.34M	$34.22M	$29.33M
YoY Change	75.7%	146.58%	271.24%
Income Tax	$8.931M	$8.896M	$8.213M
% Of Pretax Income	26.0%	26.0%	28.0%
Net Earnings	$25.41M	$25.32M	$21.12M
YoY Change	85.73%	160.68%	306.06%
Net Earnings / Revenue	28.14%	30.87%	29.34%
Basic Earnings Per Share	$1.22	$1.18	$0.99
Diluted Earnings Per Share	$0.95	$0.91	$748.8K
COMMON SHARES
Basic Shares Outstanding	20.86M shares	21.37M shares	21.22K shares
Diluted Shares Outstanding	26.65K shares	27.69M shares	28.20K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.94M	$11.35M	$21.73M
YoY Change	-55.05%	-73.69%	136.15%
Cash & Equivalents	$12.94M	$11.35M	$21.73M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$89.69M	$113.3M	$141.7M
Other Receivables	$776.0K	$1.383M	$1.673M
Total Short-Term Assets	$103.4M	$126.1M	$165.1M
YoY Change	-57.9%	-59.97%	-52.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.700M	$1.355M	$8.622M
YoY Change	-85.88%	-87.46%	-29.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$27.83M	$24.37M	$183.5M
YoY Change	-83.66%	-86.68%	-1.84%
Total Long-Term Assets	$2.547B	$2.374B	$2.112B
YoY Change	36.87%	32.74%	21.04%
TOTAL ASSETS
Total Short-Term Assets	$103.4M	$126.1M	$165.1M
Total Long-Term Assets	$2.547B	$2.374B	$2.112B
Total Assets	$2.651B	$2.500B	$2.278B
YoY Change	25.82%	18.86%	8.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.89M	$55.61M	$48.46M
YoY Change	27.08%	34.61%	28.21%
Accrued Expenses	$4.749M	$6.213M	$7.684M
YoY Change	-54.65%	-32.05%	-27.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$55.63M	$61.82M	$56.15M
YoY Change	10.14%	22.53%	16.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.377B	$2.240B	$2.038B
YoY Change	25.44%	17.62%	6.74%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.377B	$2.240B	$2.038B
YoY Change	25.44%	17.62%	6.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.63M	$61.82M	$56.15M
Total Long-Term Liabilities	$2.377B	$2.240B	$2.038B
Total Liabilities	$2.432B	$2.302B	$2.094B
YoY Change	25.04%	17.75%	6.97%
SHAREHOLDERS EQUITY
Retained Earnings	$188.4M	$163.0M
YoY Change
Common Stock	$31.43M	$36.95M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$218.2M	$198.3M	$170.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.651B	$2.500B	$2.278B
YoY Change	25.82%	18.86%	8.67%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$25.41M	$25.32M	$21.12M
YoY Change	85.73%	160.68%	306.06%
Depreciation, Depletion And Amortization	$406.0K	$385.0K	$417.0K
YoY Change	-0.73%	-7.67%	4.25%
Cash From Operating Activities	$45.07M	$51.37M	$68.30M
YoY Change	-11.04%	9.28%	4.43%
INVESTING ACTIVITIES
Capital Expenditures	-$750.0K	-$753.0K	-$275.0K
YoY Change	43.4%	20.67%	-31.25%
Acquisitions
YoY Change
Other Investing Activities	-$167.4M	-$258.1M	-$139.2M
YoY Change	168.26%	2350.87%	-673.01%
Cash From Investing Activities	-$168.1M	-$258.9M	-$139.5M
YoY Change	167.22%	2220.54%	-683.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	127.4M	189.6M	80.95M
YoY Change	-1087.99%	-3488.78%	-224.92%
NET CHANGE
Cash From Operating Activities	45.07M	51.37M	68.30M
Cash From Investing Activities	-168.1M	-258.9M	-139.5M
Cash From Financing Activities	127.4M	189.6M	80.95M
Net Change In Cash	4.337M	-17.91M	9.728M
YoY Change	-117.25%	-159.19%	-60.29%
FREE CASH FLOW
Cash From Operating Activities	$45.07M	$51.37M	$68.30M
Capital Expenditures	-$750.0K	-$753.0K	-$275.0K
Free Cash Flow	$45.82M	$52.12M	$68.58M
YoY Change	-10.49%	9.43%	4.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000889609
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021Q2	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20860328	shares
	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2895000	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-11416
	dei	Entity Registrant Name EntityRegistrantName	CONSUMER PORTFOLIO SERVICES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0459135
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 Howard Hughes Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89169
	dei	City Area Code CityAreaCode	(949)
	dei	Local Phone Number LocalPhoneNumber	753-6800
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	CPSS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11348000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29928000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	157021000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	146620000	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	2174133000	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1749098000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	149010000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	232390000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35672000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	56206000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	113338000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	176184000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1355000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1129000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	17523000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19575000	usd
CY2022Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1383000	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	2269000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24372000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	36947000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34775000	usd
CY2022Q2	us-gaap	Assets Assets	2500473000	usd
CY2021Q4	us-gaap	Assets Assets	2159578000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	62415000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	43648000	usd
CY2022Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	228906000	usd
CY2021Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	105610000	usd
CY2022Q2	cpss	Residual Interest Financing ResidualInterestFinancing	49497000	usd
CY2021Q4	cpss	Residual Interest Financing ResidualInterestFinancing	53682000	usd
CY2022Q2	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	1934156000	usd
CY2021Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	1759972000	usd
CY2022Q2	us-gaap	Subordinated Debt SubordinatedDebt	27208000	usd
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	26459000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2302182000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1989371000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21206839	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21206839	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21143764	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21143764	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	55298000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	162966000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	116531000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1622000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1622000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	198291000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	170207000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2500473000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2159578000	usd
CY2022Q2	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	75670000	usd
CY2021Q2	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	65440000	usd
	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	145730000	usd
	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	131533000	usd
CY2022Q2	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-4700000	usd
CY2021Q2	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-0	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-7100000	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	4417000	usd
CY2022Q2	us-gaap	Other Operating Income OtherOperatingIncome	1648000	usd
CY2021Q2	us-gaap	Other Operating Income OtherOperatingIncome	1329000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	3554000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	2765000	usd
CY2022Q2	us-gaap	Revenues Revenues	82018000	usd
CY2021Q2	us-gaap	Revenues Revenues	66769000	usd
	us-gaap	Revenues Revenues	156384000	usd
	us-gaap	Revenues Revenues	129881000	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	20591000	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	19448000	usd
	us-gaap	Salaries And Wages SalariesAndWages	42743000	usd
	us-gaap	Salaries And Wages SalariesAndWages	39607000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8280000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7831000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16511000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15579000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	18771000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	18980000	usd
	us-gaap	Interest Expense InterestExpense	35171000	usd
	us-gaap	Interest Expense InterestExpense	39925000	usd
CY2022Q2	cpss	Provision For Credit Losses ProvisionForCreditLosses	-8000000	usd
CY2021Q2	cpss	Provision For Credit Losses ProvisionForCreditLosses	0	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	-17400000	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	0	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5838000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4201000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11224000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8187000	usd
CY2022Q2	us-gaap	Occupancy Net OccupancyNet	1937000	usd
CY2021Q2	us-gaap	Occupancy Net OccupancyNet	2016000	usd
	us-gaap	Occupancy Net OccupancyNet	3789000	usd
	us-gaap	Occupancy Net OccupancyNet	3918000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	385000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	417000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	802000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	845000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	47802000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	52893000	usd
	us-gaap	Operating Expenses OperatingExpenses	92840000	usd
	us-gaap	Operating Expenses OperatingExpenses	108061000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	34216000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	13876000	usd
	us-gaap	Profit Loss ProfitLoss	63544000	usd
	us-gaap	Net Income Loss NetIncomeLoss	46435000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14877000	usd
	us-gaap	Profit Loss ProfitLoss	21820000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8896000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4163000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17109000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6943000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	25320000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	9713000	usd
	us-gaap	Net Income Loss NetIncomeLoss	46435000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14877000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21370000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22842000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21296000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22791000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27687000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25130000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27943000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25048000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	25320000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	9713000	usd
	us-gaap	Net Income Loss NetIncomeLoss	46435000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14877000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-25320000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-9713000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-46435000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-14877000	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	us-gaap	Accretion Expense AccretionExpense	651000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-60766000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-66812000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	802000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	845000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3628000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3598000	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-7100000	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	4417000	usd
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-17400000	usd
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1518000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	735000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-886000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1416000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2052000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1381000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-9316000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-8644000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18767000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9030000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	119670000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	112406000	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-80246000	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-142464000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	904475000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	485117000	usd
	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	425774000	usd
	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	355439000	usd
	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-1087000	usd
	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-982000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1028000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1024000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-398396000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12744000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	712400000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	470545000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	2682000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	5684000	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1933000	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1002000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	124606000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-42560000	usd
	cpss	Net Proceeds From Repayment Of Residual Interest Financing Debt NetProceedsFromRepaymentOfResidualInterestFinancingDebt	4311000	usd
	cpss	Net Proceeds From Repayment Of Residual Interest Financing Debt NetProceedsFromRepaymentOfResidualInterestFinancingDebt	-42332000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	536824000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	541065000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6204000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3872000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34285000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1582000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14416000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1125000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	270547000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-70395000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8179000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	54755000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176548000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	144152000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168369000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	198907000	usd
	us-gaap	Interest Paid Net InterestPaidNet	30809000	usd
	us-gaap	Interest Paid Net InterestPaidNet	36665000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4796000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2962000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	170207000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	170207000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	198291000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	148517000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	198291000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	148517000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zgjjWJ011sef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_866_zFerAmYc6Hpg">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, as well as the reported amounts of income and expenses during the reported periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p>
CY2022Q2	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	4700000	usd
	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	7100000	usd
	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	4400000	usd
CY2022Q2	us-gaap	Other Operating Income OtherOperatingIncome	1648000	usd
CY2021Q2	us-gaap	Other Operating Income OtherOperatingIncome	1329000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	3554000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	2765000	usd
CY2022Q2	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	25819000	usd
CY2021Q4	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	25819000	usd
CY2022Q2	cpss	Accumulated Amortization Rightofuse Assets AccumulatedAmortizationRightofuseAssets	20296000	usd
CY2021Q4	cpss	Accumulated Amortization Rightofuse Assets AccumulatedAmortizationRightofuseAssets	17624000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5523000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8195000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6213000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9058000	usd
CY2022Q2	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3407000	usd
CY2021Q4	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3407000	usd
CY2022Q2	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	2853000	usd
CY2021Q4	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	2348000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	554000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1059000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	597000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1124000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1760000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1793000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3630000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3630000	usd
CY2022Q2	cpss	Finance Lease Cost FinanceLeaseCost	257000	usd
CY2021Q2	cpss	Finance Lease Cost FinanceLeaseCost	308000	usd
	cpss	Finance Lease Cost FinanceLeaseCost	555000	usd
	cpss	Finance Lease Cost FinanceLeaseCost	616000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	2017000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	2101000	usd
	us-gaap	Lease Cost LeaseCost	4185000	usd
	us-gaap	Lease Cost LeaseCost	4246000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1907000	usd
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1892000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3965000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3822000	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	245000	usd
CY2021Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	278000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	527000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	552000	usd
CY2022Q2	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	12000	usd
CY2021Q2	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	30000	usd
	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	28000	usd
	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	65000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1500000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	728000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	327000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	735000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12400000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11400000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7185000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13075000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9685000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	57800000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	42100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12200000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1900000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2661000	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zenDrCZ0jEoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86F_zDQVjpl5zcO1">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	149000000.0	usd
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	232400000	usd
CY2022Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	149010000	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	232390000	usd
CY2022Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2200000	usd
CY2021Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2700000	usd
CY2022Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	149010000	usd
CY2021Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	232390000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	6671000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	45001000	usd
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	73497000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	56206000	usd
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	80790000	usd
CY2022Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-8000000	usd
CY2021Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-17400000	usd
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4446000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6699000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	9805000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	18820000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3117000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	5444000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	10272000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35672000	usd
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	72242000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35672000	usd
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	72242000	usd
CY2022Q2	us-gaap	Other Foreclosed Assets OtherForeclosedAssets	3015000	usd
CY2021Q4	us-gaap	Other Foreclosed Assets OtherForeclosedAssets	4341000	usd
	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-1632000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-1871000	usd
CY2022Q2	cpss	Other Foreclosed Assets Net OtherForeclosedAssetsNet	1383000	usd
CY2021Q4	cpss	Other Foreclosed Assets Net OtherForeclosedAssetsNet	2470000	usd
CY2022Q2	cpss	Receivables Pledged ReceivablesPledged	2151560000	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	9832000	usd
CY2022Q2	cpss	Securitization Trust Debt Initial Principal SecuritizationTrustDebtInitialPrincipal	5246634000	usd
CY2022Q2	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	1947529000	usd
CY2021Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	1771953000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	377600000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	801400000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	256800000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	249200000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	146400000	usd
CY2022Q2	cpss	Long Term Debt Maturities Repayments Of Principal In Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix	85800000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	16900000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	13400000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	12000000.0	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	157000000.0	usd
CY2022Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	307824000	usd
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	186780000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	130800000	usd
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	18491000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	21146000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	40590000	usd
CY2022Q2	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	65730000	usd
CY2021Q2	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	46943000	usd
	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	124470000	usd
	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	90931000	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	108000	usd
CY2021Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	6000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	114000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	12000	usd
CY2022Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	75670000	usd
CY2021Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	65440000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	145730000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	131533000	usd
CY2021Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4200000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6900000	usd
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30	pure
CY2022Q2	us-gaap	Interest Expense InterestExpense	18771000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	18980000	usd
	us-gaap	Interest Expense InterestExpense	35171000	usd
	us-gaap	Interest Expense InterestExpense	39925000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21370000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22842000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21296000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22791000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6317000	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2288000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6647000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2257000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27687000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25130000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27943000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25048000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	824000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	692000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6900000	shares
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17523000	usd
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8900000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17100000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.32	pure
	cpss	Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation Text Bloc FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBloc	<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBloc_pn3n3_zK0mYjWoj885" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (9) Fair Value Measurements (Details - Reconciliation of Finance Receivables)"> <tr style="vertical-align: bottom"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span id="xdx_8BE_zzK1nerZc0Yj" style="display: none">Schedule of reconciliation of the finance receivables measured at fair value on a recurring basis</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(In thousands)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(In thousands)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 44%">Balance at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ReceivablesFairValueDisclosure_iS_pn3n3_c20220401__20220630_z5qRQZaKTri3" style="width: 11%; text-align: right" title="Balance at beginning of period">1,903,857</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ReceivablesFairValueDisclosure_iS_pn3n3_c20210401__20210630_ze1rVcEXGD6d" style="width: 11%; text-align: right" title="Balance at beginning of period">1,533,723</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ReceivablesFairValueDisclosure_iS_pn3n3_c20220101__20220630_z9My2ZbzuIYa" style="width: 11%; text-align: right" title="Balance at beginning of period">1,749,098</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ReceivablesFairValueDisclosure_iS_pn3n3_c20210101__20210630_zJNMFCbVsNSa" style="width: 11%; text-align: right" title="Balance at beginning of period">1,523,726</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Finance receivables at fair value acquired during period</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PaymentsToAcquireFinanceReceivables_pn3n3_c20220401__20220630_zv7d7XiD0qWe" style="text-align: right" title="Finance receivables at fair value acquired during period">511,068</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PaymentsToAcquireFinanceReceivables_pn3n3_c20210401__20210630_zcF5rDAit2rd" style="text-align: right" title="Finance receivables at fair value acquired during period">279,658</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PaymentsToAcquireFinanceReceivables_c20220101__20220630_pn3n3" style="text-align: right" title="Finance receivables at fair value acquired during period">904,475</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PaymentsToAcquireFinanceReceivables_c20210101__20210630_pn3n3" style="text-align: right" title="Finance receivables at fair value acquired during period">485,117</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Payments received on finance receivables at fair value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--PaymentsOnFinanceReceivablesAtFairValue_pn3n3_c20220401__20220630_zn5vIg66dbRl" style="text-align: right" title="Payments received on finance receivables at fair value">(215,930</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--PaymentsOnFinanceReceivablesAtFairValue_pn3n3_c20210401__20210630_zSQ0rz6Uo3n7" style="text-align: right" title="Payments received on finance receivables at fair value">(199,419</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--PaymentsOnFinanceReceivablesAtFairValue_c20220101__20220630_pn3n3" style="text-align: right" title="Payments received on finance receivables at fair value">(425,774</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--PaymentsOnFinanceReceivablesAtFairValue_c20210101__20210630_pn3n3" style="text-align: right" title="Payments received on finance receivables at fair value">(355,439</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Net interest income accretion on fair value receivables</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--NetInterestIncomeAccretionOnFairValueReceivables_pn3n3_c20220401__20220630_zOMTo07g6uD1" style="text-align: right" title="Net interest income accretion on fair value receivables">(29,562</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--NetInterestIncomeAccretionOnFairValueReceivables_pn3n3_c20210401__20210630_zsyMrAXWW2Wd" style="text-align: right" title="Net interest income accretion on fair value receivables">(31,787</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--NetInterestIncomeAccretionOnFairValueReceivables_c20220101__20220630_pn3n3" style="text-align: right" title="Net interest income accretion on fair value receivables">(60,766</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--NetInterestIncomeAccretionOnFairValueReceivables_c20210101__20210630_pn3n3" style="text-align: right" title="Net interest income accretion on fair value receivables">(66,812</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Mark to fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--MarkToFairValue_pn3n3_c20220401__20220630_z6n5BDJ5a9Qe" style="border-bottom: Black 1pt solid; text-align: right" title="Mark to fair value">4,700</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--MarkToFairValue_pn3n3_d0_c20210401__20210630_zpocd7BYEdD" style="border-bottom: Black 1pt solid; text-align: right" title="Mark to fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--MarkToFairValue_c20220101__20220630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Mark to fair value">7,100</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--MarkToFairValue_c20210101__20210630_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Mark to fair value">(4,417</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ReceivablesFairValueDisclosure_iE_pn3n3_c20220401__20220630_zGiYaSdfmJH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Receivables, Fair Value Disclosure">2,174,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ReceivablesFairValueDisclosure_iE_pn3n3_c20210401__20210630_z8ppZYebhmJ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Receivables, Fair Value Disclosure">1,582,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ReceivablesFairValueDisclosure_iE_pn3n3_c20220101__20220630_zjXGEY5CApmf" style="border-bottom: Black 2.5pt double; text-align: right" title="Receivables, Fair Value Disclosure">2,174,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ReceivablesFairValueDisclosure_iE_pn3n3_c20210101__20210630_zN0KzBGwlD49" style="border-bottom: Black 2.5pt double; text-align: right" title="Receivables, Fair Value Disclosure">1,582,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1903857000	usd
CY2021Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1533723000	usd
CY2021Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1749098000	usd
CY2020Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1523726000	usd
CY2022Q2	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	511068000	usd
CY2021Q2	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	279658000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	904475000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	485117000	usd
CY2022Q2	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-215930000	usd
CY2021Q2	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-199419000	usd
	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-425774000	usd
	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-355439000	usd
CY2022Q2	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-29562000	usd
CY2021Q2	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-31787000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-60766000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-66812000	usd
CY2022Q2	cpss	Mark To Fair Value MarkToFairValue	4700000	usd
CY2021Q2	cpss	Mark To Fair Value MarkToFairValue	0	usd
	cpss	Mark To Fair Value MarkToFairValue	7100000	usd
	cpss	Mark To Fair Value MarkToFairValue	-4417000	usd
CY2022Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2174133000	usd
CY2021Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1582175000	usd
CY2022Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2174133000	usd
CY2021Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1582175000	usd
CY2022Q2	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	2402830000	usd
CY2022Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2174133000	usd
CY2021Q4	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	1972699000	usd
CY2021Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1749098000	usd
	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	9.9% - 11.3%
CY2021	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	10.6% - 11.3%
	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	10.0% - 18.4%
CY2021	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	10.0% - 18.4%
CY2022Q2	cpss	Finance Receivables Measured At Fair Value FinanceReceivablesMeasuredAtFairValue	2402830000	usd
CY2021Q4	cpss	Finance Receivables Measured At Fair Value FinanceReceivablesMeasuredAtFairValue	1972699000	usd
CY2022Q2	us-gaap	Foreclosed Assets ForeclosedAssets	1400000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11348000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	157021000	usd
CY2022Q2	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	101305000	usd
CY2022Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1383000	usd
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	228906000	usd
CY2022Q2	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	4302000	usd
CY2022Q2	us-gaap	Secured Debt SecuredDebt	1829109000	usd
CY2022Q2	us-gaap	Subordinated Debt SubordinatedDebt	27208000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29928000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	146620000	usd
CY2021Q4	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	178795000	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	2269000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	105610000	usd
CY2021Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	3568000	usd
CY2021Q4	us-gaap	Secured Debt SecuredDebt	1740901000	usd
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	26459000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001683168-22-005436-index-headers.html	Edgar Link	pending
0001683168-22-005436-index.html	Edgar Link	pending
0001683168-22-005436.txt	Edgar Link	pending
0001683168-22-005436-xbrl.zip	Edgar Link	pending
cpss-20220630.xsd	Edgar Link	pending
cpss-20220630_pre.xml	Edgar Link	unprocessable
cpss-20220630_def.xml	Edgar Link	unprocessable
cps_ex3101.htm	Edgar Link	pending
cps_ex3102.htm	Edgar Link	pending
cps_ex3200.htm	Edgar Link	pending
cps_i10q-063022.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
cps_i10q-063022_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpss-20220630_cal.xml	Edgar Link	unprocessable
cpss-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSS
Consumer Portfolio Services Inc Stock $cpss

2022 Q3 Form 10-Q Financial Statement

#000168316822005436 Filed on August 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS Consumer Portfolio Services Inc Stock $cpss

2022 Q3 Form 10-Q Financial Statement

#000168316822005436 Filed on August 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS
Consumer Portfolio Services Inc Stock $cpss